PFIZER INC: $1.1B Department of Health and Human Services Contract Vehicle
Summary
Pfizer Inc receives a $1.1B contract from the CDC, providing a meaningful 1.85% revenue boost to a company facing declining post-COVID sales. This award supports Pfizer's healthcare segment and stabilizes its financial outlook.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.$1.1B CDC contract provides ~1.85% revenue boost to Pfizer
- 2.Contract stabilizes Pfizer's declining post-COVID revenue
- 3.No direct legislative authorization, but aligns with public health spending
Market Implications
This contract provides a modest but meaningful revenue boost to Pfizer, which has been struggling with declining sales after the COVID-19 pandemic. The award could help stabilize investor sentiment and support the stock price in the near term. However, given the contract's size relative to Pfizer's overall revenue, it is not a transformative catalyst. Investors should monitor for additional CDC contracts or broader public health funding that could further benefit Pfizer.
Full Analysis
- The contract: Pfizer Inc has been awarded a $1.1B indefinite delivery/indefinite quantity contract by the Centers for Disease Control and Prevention (CDC), under the Department of Health and Human Services. The contract period runs from April 2025 to March 2026, and the description 'END OF PWS' suggests it is a continuation or final phase of a prior statement of work, likely for vaccines or medical countermeasures. 2) The public company beneficiary: Pfizer Inc is the direct recipient. With FY2025 revenue of $59.6B, this $1.1B award represents about 1.85% of annual revenue—a significant but not transformative boost. Given Pfizer's net income of $2.1B and net margin of 3.56%, this contract could add roughly $39M to net income (assuming similar margins), improving profitability. 3) Connection to legislation: No related bill signals directly authorize this contract, but it aligns with ongoing public health funding through HHS appropriations. The contract may be part of broader pandemic preparedness or routine vaccine programs. 4) Supply chain winners: Key suppliers to Pfizer include contract manufacturing organizations (CMOs) like Thermo Fisher Scientific ($TMO) for biologics production, and raw material suppliers like Merck KGaA (private) or Lonza Group (private). Smaller-cap suppliers such as BioNTech ($BNTX) could benefit if the contract involves mRNA technology, though Pfizer's supply chain is diversified. 5) Historical pattern: Similar CDC contracts for vaccine procurement have historically provided stable, recurring revenue for pharmaceutical companies. For example, prior CDC contracts with Pfizer for Prevnar or COVID-19 vaccines have supported consistent cash flows. This award likely signals continued government investment in infectious disease prevention, which is a tailwind for vaccine developers.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
GEORGIA EMERGENCY MANAGEMENT AND HOMELAND SECURITY AGENCY: $1.6B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
NORTH CAROLINA DEPARTMENT OF PUBLIC SAFETY: $2.4B Department of Homeland Security Grant
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.0B Department of Health and Human Services Grant
DEPARTMENT OF SOCIAL SERVICES CONNECTICUT: $6.9B Department of Health and Human Services Grant
STATE OF COLORADO - DEPT OF HEALTH CARE POLICY & FINANCING: $9.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Contract Details
Recipient
PFIZER INC
Award Amount
$1,123,734,612
Awarding Agency
Department of Health and Human Services
Sub-Agency
Centers for Disease Control and Prevention
Contract Type
INDEFINITE DELIVERY / INDEFINITE QUANTITY
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →